- Home
- MYO vs KOD Comparison
MYO vs KOD Comparison
Compare MYO & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- KOD
- Stock Information
- Founded
- MYO 2004
- KOD 2009
- Country
- MYO United States
- KOD United States
- Employees
- MYO N/A
- KOD N/A
- Industry
- MYO Industrial Specialties
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYO Health Care
- KOD Health Care
- Exchange
- MYO Nasdaq
- KOD Nasdaq
- Market Cap
- MYO 157.9M
- KOD 186.3M
- IPO Year
- MYO 2017
- KOD 2018
- Fundamental
- Price
- MYO $6.23
- KOD $8.72
- Analyst Decision
- MYO Strong Buy
- KOD Hold
- Analyst Count
- MYO 4
- KOD 5
- Target Price
- MYO $8.25
- KOD $6.80
- AVG Volume (30 Days)
- MYO 368.8K
- KOD 484.9K
- Earning Date
- MYO 11-06-2024
- KOD 11-14-2024
- Dividend Yield
- MYO N/A
- KOD N/A
- EPS Growth
- MYO N/A
- KOD N/A
- EPS
- MYO N/A
- KOD N/A
- Revenue
- MYO $25,239,125.00
- KOD N/A
- Revenue This Year
- MYO $53.19
- KOD N/A
- Revenue Next Year
- MYO $39.01
- KOD N/A
- P/E Ratio
- MYO N/A
- KOD N/A
- Revenue Growth
- MYO 36.23
- KOD N/A
- 52 Week Low
- MYO $2.51
- KOD $2.19
- 52 Week High
- MYO $6.75
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- MYO 61.36
- KOD 64.72
- Support Level
- MYO $5.80
- KOD $8.03
- Resistance Level
- MYO $6.14
- KOD $9.55
- Average True Range (ATR)
- MYO 0.47
- KOD 0.89
- MACD
- MYO -0.05
- KOD -0.08
- Stochastic Oscillator
- MYO 57.33
- KOD 36.51
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.